Schapiro JM - Search Results

1

Survival of hepatitis C-infected haemophilia patients is predicted by presence of cirrhosis but not by anti-viral treatment.

Maor Y, Schapiro JM, Bashari D, Martinowitz U. Maor Y, et al. Among authors: schapiro jm. Ann Hepatol. 2014 Nov-Dec;13(6):753-61. Ann Hepatol. 2014. PMID: 25332261 Free article.

2

Drug-induced and traumatic nail problems in the haemophilias.

Heim M, Schapiro J, Wershavski M, Martinowitz U. Heim M, et al. Haemophilia. 2000 May;6(3):191-4. doi: 10.1046/j.1365-2516.2000.00388.x. Haemophilia. 2000. PMID: 10792478

3

Hepatitis C at the israeli national hemophilia center.

Maor Y, Bashari D, Kenet G, Lalezari S, Lubetsky A, Luboshitz J, Schapiro JM, Avidan B, Bar-Meir S, Martinowitz U. Maor Y, et al. Among authors: schapiro jm. Haemophilia. 2006 Jan;12(1):68-74. doi: 10.1111/j.1365-2516.2006.01178.x. Haemophilia. 2006. PMID: 16409178

4

Non-invasive biomarkers of liver fibrosis in haemophilia patients with hepatitis C: can you avoid liver biopsy?

Maor Y, Bashari D, Kenet G, Lubetsky A, Luboshitz J, Schapiro JM, Pénaranda G, Bar-Meir S, Martinowitz U, Halfon P. Maor Y, et al. Among authors: schapiro jm. Haemophilia. 2006 Jul;12(4):372-9. doi: 10.1111/j.1365-2516.2006.01290.x. Haemophilia. 2006. PMID: 16834736

5

Improving estimation of liver fibrosis using combination and newer noninvasive biomarker scoring systems in hepatitis C-infected haemophilia patients.

Maor Y, Calès P, Bashari D, Kenet G, Lubetsky A, Luboshitz J, Schapiro JM, Pénaranda G, Bar-Meir S, Martinowitz U, Halfon P. Maor Y, et al. Among authors: schapiro jm. Haemophilia. 2007 Nov;13(6):722-9. doi: 10.1111/j.1365-2516.2007.01548.x. Haemophilia. 2007. PMID: 17973848

6

Treatment of hepatitis C in patients with haemophilia - the Israeli National Hemophilia Center experience.

Maor Y, Schapiro JM, Bashari D, Lurie Y, Safadi R, Segol O, Paritsky M, Rachlis Z, Avidan B, Bar-Meir S, Martinowitz U. Maor Y, et al. Among authors: schapiro jm. Haemophilia. 2008 Mar;14(2):336-42. doi: 10.1111/j.1365-2516.2007.01633.x. Epub 2008 Jan 16. Haemophilia. 2008. PMID: 18205802

7

Genetic polymorphism of IL28B in hepatitis C-infected haemophilia patients in Israel.

Maor Y, Morali G, Bashari D, Pénaranda G, Schapiro JM, Martinowitz U, Halfon P. Maor Y, et al. Among authors: schapiro jm. Haemophilia. 2013 Jan;19(1):150-6. doi: 10.1111/j.1365-2516.2012.02932.x. Epub 2012 Aug 23. Haemophilia. 2013. PMID: 22913807

8

Emicizumab prophylaxis in haemophilia patients older than 50 years with cardiovascular risk factors: Real-world data.

Misgav M, Brutman-Barazani T, Budnik I, Avishai E, Schapiro J, Bashari D, Barg AA, Lubetsky A, Livnat T, Kenet G. Misgav M, et al. Haemophilia. 2021 Mar;27(2):253-260. doi: 10.1111/hae.14261. Epub 2021 Feb 17. Haemophilia. 2021. PMID: 33595174

9

Genetic variation at NNRTI resistance-associated positions in patients infected with HIV-1 subtype C.

Grossman Z, Istomin V, Averbuch D, Lorber M, Risenberg K, Levi I, Chowers M, Burke M, Bar Yaacov N, Schapiro JM; Israel AIDS Multi-Center Study Group. Grossman Z, et al. Among authors: schapiro jm. AIDS. 2004 Apr 9;18(6):909-15. doi: 10.1097/00002030-200404090-00008. AIDS. 2004. PMID: 15060438

10

Baseline CD4(+) T-cell counts and weighted background susceptibility scores strongly predict response to maraviroc regimens in treatment-experienced patients.

Schapiro JM, Boucher CA, Kuritzkes DR, van de Vijver DA, Llibre JM, Lewis M, Simpson P, Delogne C, McFadyen L, Chapman D, Perros M, Valdez H, van der Ryst E, Westby M. Schapiro JM, et al. Antivir Ther. 2011;16(3):395-404. doi: 10.3851/IMP1759. Antivir Ther. 2011. PMID: 21555822

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

145 results

Search Page

Filters